Department of Physical Medicine and Rehabilitation, AP-HP, CHU Lariboisière, Paris, France; Université Paris Cité, Inserm, MASCOT, Paris, France; Université Paris Cité, Institut des Sciences du Sport-Santé de Paris, Paris, France.
Nantes Université, CHU Nantes, IICiMed, UR 1155, Nantes, France.
J Rehabil Med. 2024 Oct 18;56:jrm41225. doi: 10.2340/jrm.v56.41225.
The primary aim of this study was to evaluate the safety and efficacy of early mobilization in patients with aneurysmal subarachnoid haemorrhage.
Systematic review with meta-analysis of randomized controlled studies and observational studies.
Patients with aneurysmal subarachnoid haemorrhage.
PubMed, Embase, CINAHL, Web of Science, Pedro, and the Cochrane Library databases were searched. A systematic review and meta-analysis were performed. Screening and data extraction were performed by 2 independent reviewers.
Sixteen studies involving 1,757 patients were included. Meta-analysis of the data estimated that early mobilization improved mRS score at discharge (mean difference -1.39, 95% CI -2.51 to -0.28, I2 = 86%) and at 3 months (mean difference -1.10, 95% CI -1.54 to -0.66, I2 = 7%). Early mobilization was associated with a reduction in cerebral vasospasm rate, both radiological (OR 0.66, 95% CI 0.45 to 0.96, I2 = 7%) and clinical (OR 0.44, 95% CI 0.27 to 0.72, I2 = 8%); 6% of mobilization sessions involved adverse events, mostly haemodynamic changes.
This review found moderate-quality evidence supporting the safety and effectiveness of early mobilization in patients with SAH. Further randomized controlled trials are needed to identify the appropriate mobilization strategy and confirm these results.
本研究的主要目的是评估动脉瘤性蛛网膜下腔出血患者早期活动的安全性和有效性。
对随机对照研究和观察性研究进行系统评价和荟萃分析。
动脉瘤性蛛网膜下腔出血患者。
检索 PubMed、Embase、CINAHL、Web of Science、Pedro 和 Cochrane 图书馆数据库。进行系统评价和荟萃分析。由 2 名独立评审员进行筛选和数据提取。
纳入了 1757 例患者的 16 项研究。荟萃分析数据估计,早期活动可改善出院时(平均差异 -1.39,95%CI-2.51 至 -0.28,I2=86%)和 3 个月时(平均差异 -1.10,95%CI-1.54 至 -0.66,I2=7%)的 mRS 评分。早期活动与降低脑血管痉挛率相关,包括影像学(OR 0.66,95%CI 0.45 至 0.96,I2=7%)和临床(OR 0.44,95%CI 0.27 至 0.72,I2=8%);6%的活动课程涉及不良事件,主要是血流动力学变化。
本综述发现了中等质量的证据支持 SAH 患者早期活动的安全性和有效性。需要进一步的随机对照试验来确定适当的活动策略并确认这些结果。